Correlation Between Adagene and INmune Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Adagene and INmune Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adagene and INmune Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adagene and INmune Bio, you can compare the effects of market volatilities on Adagene and INmune Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adagene with a short position of INmune Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adagene and INmune Bio.

Diversification Opportunities for Adagene and INmune Bio

-0.3
  Correlation Coefficient

Very good diversification

The 3 months correlation between Adagene and INmune is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Adagene and INmune Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INmune Bio and Adagene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adagene are associated (or correlated) with INmune Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INmune Bio has no effect on the direction of Adagene i.e., Adagene and INmune Bio go up and down completely randomly.

Pair Corralation between Adagene and INmune Bio

Given the investment horizon of 90 days Adagene is expected to under-perform the INmune Bio. But the stock apears to be less risky and, when comparing its historical volatility, Adagene is 1.93 times less risky than INmune Bio. The stock trades about -0.1 of its potential returns per unit of risk. The INmune Bio is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  465.00  in INmune Bio on December 29, 2024 and sell it today you would earn a total of  287.00  from holding INmune Bio or generate 61.72% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Adagene  vs.  INmune Bio

 Performance 
       Timeline  
Adagene 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Adagene has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
INmune Bio 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in INmune Bio are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak primary indicators, INmune Bio sustained solid returns over the last few months and may actually be approaching a breakup point.

Adagene and INmune Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Adagene and INmune Bio

The main advantage of trading using opposite Adagene and INmune Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adagene position performs unexpectedly, INmune Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INmune Bio will offset losses from the drop in INmune Bio's long position.
The idea behind Adagene and INmune Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities